The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies

Qinfeng Zhou1, Dacheng Xie2, Rong Wang1

  • 1Department of Laboratory Medicine, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, China.

Biomarker Research
|May 3, 2022
PubMed

Insights

Circular RNAs (circRNAs), acting as miRNA sponges, are crucial in intercellular communication via exosomes. Exosomal circRNAs are emerging biomarkers for both solid tumors and hematological malignancies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are novel noncoding RNAs with diverse biological functions.
  • Exosomes are key mediators of intercellular communication, originating from multivesicular bodies.
  • Exosomal circRNAs are increasingly implicated in cancer progression and intercellular signaling.

Purpose of the Study:

  • To review the properties and functions of circRNAs and exosomes.
  • To elucidate the mechanisms and roles of exosomal circRNAs in malignant tumors.
  • To highlight the potential of exosomal circRNAs as biomarkers for cancer diagnosis and prognosis.

Main Methods:

  • Literature review of recent studies on circRNAs, exosomes, and cancer.
  • Analysis of molecular mechanisms involving exosomal circRNAs.
  • Synthesis of evidence on the role of exosomal circRNAs in solid and hematological malignancies.

Main Results:

  • CircRNAs function as miRNA sponges, regulate gene transcription, splicing, and protein interactions.
  • Exosomes facilitate intercellular communication, transporting various molecules including circRNAs.
  • Exosomal circRNAs are significantly associated with tumor invasion, metastasis, and hematological malignancies.

Conclusions:

  • Exosomal circRNAs represent a critical mechanism in cancer development and progression.
  • Exosomal circRNAs hold promise as sensitive and specific biomarkers for various cancers.
  • Further research into exosomal circRNAs can lead to novel therapeutic strategies and diagnostic tools.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K